Reaction
Use Of Accessory Respiratory Muscles reporting signals
As of the last recalculation, Use Of Accessory Respiratory Muscles appears in 400 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is PALIVIZUMAB (PRR 101.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Palivizumab | 28 | 101.9 | 102.1 |
| Micafungin Sodium | 5 | 31.1 | 31.1 |
| Mepolizumab | 25 | 27.9 | 27.9 |